
Harmony Biosciences
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $268,917 | $261,280 | $215,387 | $243,776 |
Gross Profit | 188,231 | 198,082 | 170,875 | 175,231 |
EBITDA | 68,277 | 102,303 | 48,889 | 51,738 |
EBIT | 62,309 | 96,335 | 42,921 | 44,306 |
Net Income | 48,196 | 75,431 | 32,488 | 22,486 |
Net Change In Cash | 268,917 | 261,280 | 215,387 | 243,776 |
Free Cash Flow | 76,693 | 92,432 | 27,760 | 126,044 |
Cash | 647,099 | 549,769 | 589,398 | 752,502 |
Basic Shares | 59,679 | 58,769 | 58,776 | 58,696 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $868,453 | $714,734 | $582,022 | $437,855 |
Gross Profit | 670,111 | 557,919 | 460,786 | 354,374 |
EBITDA | 255,048 | 233,412 | 221,512 | 146,866 |
EBIT | 229,713 | 209,300 | 197,153 | 123,481 |
Net Income | 158,687 | 145,493 | 128,853 | 181,468 |
Net Change In Cash | 868,453 | 714,734 | 582,022 | 437,855 |
Cost of Revenue | 9,475 | |||
Free Cash Flow | 347,889 | 218,668 | 219,075 | 144,294 |
Cash | 752,502 | 453,001 | 311,660 | 243,784 |
Basic Shares | 58,544 | 57,870 | 60,372 | 61,097 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $0.81 |
2026-06-30 | $1.28 |
2026-03-31 | $0.79 |
2025-12-31 | $0.57 |